AstraZeneca CEO on Impact of Midterms on Drug Market

Pharma industry has a trust issue, AstraZeneca CEO says | CNBC ConversationПодробнее

AstraZeneca CEO talks blowout earnings, global growth, new drugs, and pricingПодробнее

Leaders with Lacqua: Astrazeneca CEO Pascal SoriotПодробнее

AstraZeneca Supports Trump's Drug-Rebate Overhaul, CEO SaysПодробнее

Astrazeneca CEO on Climate Change, China, Drug Industry ChallengesПодробнее

CEO of AstraZeneca slips up and tells the truthПодробнее

AstraZeneca CEO Pascal Soriot goes one-on-one with Jim CramerПодробнее

AstraZeneca CEO Soriot on Pharmaceuticals in ChinaПодробнее

Soriot: the CEO who fought a bidПодробнее

AstraZeneca CEO: We've increased inventory levels ahead of Brexit | Street Signs EuropeПодробнее

AstraZeneca CEO says they've reduced emissions by 60%Подробнее

AstraZeneca CEO discusses oral weight loss drug agreement with EccogeneПодробнее

AstraZeneca boss quits as sales fallПодробнее

What Embattled AstraZeneca Should Look For In A New CEOПодробнее

AstraZeneca is moving quickly with Covid antibody drug, CEO saysПодробнее

AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy DealПодробнее

AstraZeneca Takeover: MPs Question BossesПодробнее